A Study Comparing Fascia Iliaca Blockade vs Extracapsular Local Field Infiltration With Liposomal Bupivacaine
Pain Outcomes Following Hip Arthroscopy: A Prospective Randomized Control Study Comparing Fascia Iliaca Blockade vs Extracapsular Local Field Infiltration With Liposomal Bupivacaine
1 other identifier
interventional
37
1 country
1
Brief Summary
The purpose of this study is to compare the effectiveness of fascia iliaca blockade vs local field infiltration with liposomal bupivicaine in controlling pain, narcotic utilization and falls in the postoperative period following hip arthroscopy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Oct 2019
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2019
CompletedFirst Posted
Study publicly available on registry
October 3, 2019
CompletedStudy Start
First participant enrolled
October 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 17, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 17, 2020
CompletedResults Posted
Study results publicly available
May 11, 2021
CompletedMay 11, 2021
April 1, 2021
5 months
September 4, 2019
March 9, 2021
April 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Analogue Scale
pain scale Questionnaire 0 equals no pain at all and 10 equals the worst. The out come measure time frame is reported as the average VAS score of the first 4 day post op.
post op days 1-4 (Average VAS score of first 4 days of post op)
Secondary Outcomes (2)
Narcotic Utilization
total pill taken over the course of days 1-4 post op.
Total Number of at Home Falls.
Post op days 1-7
Study Arms (2)
Liposomal Bupivicaine
ACTIVE COMPARATORFollowing hip arthroscopy, local field infiltration with liposomal bupivicaine will be performed for adjunct pain control
fascia iliaca blockade
ACTIVE COMPARATORPreoperatively before hip arthroscopy, a fascia iliaca blockade will be performed for adjunct pain control
Interventions
Eligibility Criteria
You may qualify if:
- adult patients (\>18 years old)
- diagnosed FAI that are indicated for hip arthroscopic labral repair and femoroplasty/acetabuloplasty.
You may not qualify if:
- patients undergoing revision procedures, bilateral procedures,
- advanced osteoarthritis (\<2mm joint space on plain radiographs)
- frank dysplasia (anterior and/or lateral center edge angles \<20 degrees and/or Tonnis angle \>15 degrees)
- diagnoses other than FAI (Legg Calve Perthes, femoral head avascular necrosis, septic arthritis, or post traumatic deformity).
- allergy to liposomal bupivicaine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kerlan Jobe
Los Angeles, California, 90045, United States
Related Publications (2)
Mont MA, Beaver WB, Dysart SH, Barrington JW, Del Gaizo DJ. Local Infiltration Analgesia With Liposomal Bupivacaine Improves Pain Scores and Reduces Opioid Use After Total Knee Arthroplasty: Results of a Randomized Controlled Trial. J Arthroplasty. 2018 Jan;33(1):90-96. doi: 10.1016/j.arth.2017.07.024. Epub 2017 Jul 25.
PMID: 28802777BACKGROUNDKrych AJ, Baran S, Kuzma SA, Smith HM, Johnson RL, Levy BA. Utility of multimodal analgesia with fascia iliaca blockade for acute pain management following hip arthroscopy. Knee Surg Sports Traumatol Arthrosc. 2014 Apr;22(4):843-7. doi: 10.1007/s00167-013-2665-y. Epub 2013 Sep 24.
PMID: 24061718BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
We did not meet target enrollment due to safety concerns.
Results Point of Contact
- Title
- Dr. Michael Banffy
- Organization
- Cedar Sinai -Kerlan Jobe
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Banffy, MD
Cedars Sinai
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Orthopaedic Sports Medicine Fellowship
Study Record Dates
First Submitted
September 4, 2019
First Posted
October 3, 2019
Study Start
October 29, 2019
Primary Completion
March 17, 2020
Study Completion
March 17, 2020
Last Updated
May 11, 2021
Results First Posted
May 11, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share